TY  - JOUR

T1  - 019 Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (StarMS)

JO  - Journal of Neurology Neurosurgery & Psychiatry

PY  - 2022/05/27

AU  - Sharrack B

AU  - Snowden J

AU  - Muraro P

ED  - 

DO  - DOI: 10.1136/jnnp-2022-abn.58

VL  - 93

IS  - 6

SP  - a19.2

EP  - a1a19

Y2  - 2024/12/22

ER  -